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ABSTRACT
International Journal of Exercise Science 14(2): 1018-1026, 2021. Hypertrophic cardiomyopathy (HCM)

is an autosomal dominant disease that causes myocardial remodeling. Physical exercise (PE) is a therapeutic
resource used in Supervised Cardiac Rehabilitation (SCR) to improve Quality of Life (QL), reducing cardiovascular
morbidity and mortality. Therefore, the aim of this study is to report how SCR using a personalized exercise
prescription, promoted Reverse Myocardial Remodeling (RMR), improved functionality and QL of a patient with
HCM. This is a case report of a 43-year-old sedentary female patient with a Body Mass Index (BMI) of 24.7 kg/m2.
The patient was diagnosed with Septal Type Asymmetric HCM. Heart Failure (HF) grade III / IV, according to the
New York Heart Association (NYHA), was initially treated with 40mg of Propranolol Hydrochloride twice a day,
and presented with excessive fatigue, and angina. The echocardiogram showed a final diastolic volume (FDV) of
130 ml, a final systolic volume (FSV) of 44 ml, a left ventricular mass (LVM) of 236 g, interventricular septum
thickness of 14 mm, left ventricular posterior wall (LVPW) thickness of 9 mm, left atrium diameter 46 mm, left
ventricular end diastolic diameter of 52mm, septum/left ventricular wall ratio of 1.55 mm, and ejection fraction
(EF) of 66% (Teicholz). It was obtained as a result of decreased FDV 130 vs. 102ml, decreased FSV 44 vs. 32 ml,
decreased LVM 236 vs. 201 g, increased EF 66 vs. 69%, 26% improvement in QL, and 50% reduction in the dosage
of Propranolol Hydrochloride. These results suggest that a personalized SCR program is an adjuvant treatment
capable of promoting RMR and improving QL and functionality in a patient with HCM.
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INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease that causes myocardial
remodeling (concentric hypertrophy) (8). It expresses an intracellular anomaly, affecting the
spatial organization of myofilaments, and favors the development of arrhythmias, such as
supraventricular and non-sustained ventricular tachycardia/or sustained, which confers an
increased risk of sudden death (3, 8).
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HCM presents with diastolic ventricular dysfunction, preservation of systolic function, and
normal ejection fraction (EF), assessed by Echocardiogram (ECO) (3). Clinically, a decrease in
functional capacity is observed, which directly compromises the activities of daily living (ADL)
leading the individual to a progressive decline in quality of life (QL) (12). Physical exercise (PE)
is able to promote reverse myocardial remodeling (RMR) in hearts with concentric hypertrophy
and/or dilatation, as well as being a therapeutic resource used in Cardiac Rehabilitation (CR) to
improve QL and reducing cardiovascular morbidity and mortality (13).
Studies on PE in HCM showed improvement in functional capacity and QL, however, they did
not investigate RMR (4, 11). Thus, this study aims to report as a Supervised Cardiac
Rehabilitation (SCR) work, using a prescription of personalized exercise, promoted RMR,
improved functionality and QL of a patient with HCM.
METHODS
Participants
This is a case report of a sedentary female patient, 43 years of age, and a Body Mass Index (BMI)
24.7 kg/m2. At 16 years old, she was diagnosed with hypertrophic asymmetric cardiomyopathy
of septal predominance, through screening tests (electrocardiogram and ECO). These tests were
repeated annually, due to the genetic load of maternal origin. However, the symptoms did not
appear until the age of 16, accentuating at the age of 17. Since then, annual examinations have
been carried out in conjunction with family research, in which a genetic load of maternal origin
has been discovered. As of 2010, the ECO was always performed with the same
echocardiographer.
The patient was referred to the Cardiovascular Rehabilitation service at the Clinical School of
the Adventist College of Bahia, Cachoeira, Brazil (BA), in February 2019. For the treatment of
heart failure (HF) due to HCM, she used propranolol hydrochloride (40 mg) twice a day. She
presented with cardiovascular complications; among them, a picture of non-sustained
ventricular and supraventricular tachycardia determined through the 24-hour ECG-Holter
exam, HF grade III/IV according to the New York Heart Association (NYHA), excessive fatigue,
and angina on habitual efforts.
During the physical therapy evaluation, the patient answered the Minnesota Living with Heart
Failure Questionnaire (MLHFQ), with a score ranging from zero to 105, obtaining a score of 64.
She reported discomfort during sleep, a feeling of suffocation (characteristic of paroxysmal
nocturnal dyspnea), and felt it was necessary to support stand on the pillows at a 45º angle,
while remaining supine to get to sleep. She also reported great difficulty in performing activities
of daily living, such as bathing, walking, sweeping the house, hanging clothes, getting dressed,
going up and down stairs, and picking up objects in high or very low places due to dyspnea
during small efforts, as well recurrent syncope.
In the Doppler echocardiogram exam performed on April 24, 2018, the following descriptive
variables were verified: final diastolic volume: 130 ml, final systolic volume: 44 ml, left
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ventricular mass: 236 g, thickness of interventricular septum: 14 mm, thickness of left ventricular
posterior wall (LVPW): 9 mm, left atrium diameter: 46 mm, left ventricular end diastolic
diameter: 52 mm, left ventricular septum/wall ratio: 1.55 mm, and an ejection fraction of 66%
(Teicholz). The report attested moderate left ventricular diastolic dysfunction (Type II),
increased left ventricular filling pressure, moderate left atrial dilation (Type II), mild degree
mitral valve insufficiency, degree aortic valve insufficiency discreet, and concentric left
ventricular hypertrophy and dilation.
The ECG-Holter, performed on December 4, 2017, demonstrated the presence of ventricular
arrhythmias (five of which were isolated and one episode in pairs) and supraventricular
arrhythmias (115 were isolated, nineteen paired, and three non-sustained tachycardias).
According to the Brazilian Guidelines for Implantable Electronic Cardiac Devices (7), the
recommendations for implantation of an implantable cardiodefibrillator in patients with HCM
are divided into classes: Class I - Patients with HCM who have presented ventricular tachycardia
Sustained Ventricular Fibrillation of non-reversible cause and expectation life span of at least
one year, Class II - Patients with HCM who have one or more major risk factors for sudden
cardiac death and life expectancy of at least one year, Class III - HCM patients without risk
factors. After the patient underwent an evaluation with the arrhythmologist, she was not
indicated for the implantation of the implantable cardiodefibrillator. In view of the
physiotherapeutic evaluation performed and the patient's clinical condition, the objectives of
the SCR were: Increased functional capacity, improved ADL, without the patient having
dyspnea or syncope and consequently improving QL.
This case report was approved by the Research Ethics Committee of Adventist College of Bahia,
Cachoeira, BA, Brazil under CAAE nº 39825620.2.0000.0042, in accordance with the Declaration
of Helsinki. This research was carried out fully in accordance with the ethical standards of the
International Journal of Exercise Science (9).
Protocol
The individualized SCR protocol started on February 12, 2019 and lasted for five months, with
a frequency of two weekly sessions. The sessions consisted of inspiratory muscle training (IMT),
neuromuscular exercises, handgrip exercises, and cyclic exercises, performed under
electrocardiographic monitoring (ECAFIX multi-parameter cardiac monitor, Active® model,
São Paulo, SP, Brazil).
Initially, two subjective effort perception scales (SEPS) were presented and anchored to
determine the intensity of the exercises. The Borg scale applied in cyclic exercises and the SEPS
of Omni used to determine the effort of the active musculature in neuromuscular exercises. In
the first month, an adaptive training was elaborated, after that period the patient underwent a
reassessment, and the SCR protocol was updated for a conditioning training (Table 1). It is worth
noting that Borg was applied in limiting neuromuscular exercises, so that a cardiorespiratory
effort > 9 was not exceeded in the first month, and > 13 in the following months. However, the
intensity of neuromuscular exercise was determined by Omni.
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The IMT load was prescribed according to Oliveira et al. (10), which is based on the glycemic
threshold through the maximum incremental test of resistance of the inspiratory muscles. The
resistance of inspiratory muscles was assessed using POWERbreathe® K5, connected to the
computer using the BreatheLink® software. This test is characterized as non-continuous
incremental and consists of up to ten stages with an interval of two minutes between them. The
test starts with 10% of the maximum value, increases 10% at each level, with blood glucose,
Borg, blood pressure and heart rate collections at the end of each level. As the equipment only
imposes the load determined on the fourth inspiration, 19 incursions were made at each level,
with a five-second breathing cycle guided by a beep of the device. The test was interrupted on
the load in which the volunteer was unable to win it or expressed an inability to continue the
test, calling this the point of exhaustion.
The glycemic threshold was detected by means of blood collections through puncture in one of
the digital pulps. After asepsis with alcohol (70%) using lancets and disposable procedure
gloves, blood glucose values were obtained by applying the blood on a test tape attached to the
glucose monitor G-TECH free® (expressed in mg/dL) that obtained the results immediately
after contact with the blood in the lancet. The glycemic threshold was determined by visual
inspection, as the lowest value of the glycemic curve built in the test. At the point where the
glycemic threshold was found, the Borg of the obtained load was anchored. This allowed us to
evolve the load in the other months by adjusting it using the Borg. During the first month, we
opted for the IMT to be performed during the service session at the school clinic, aiming at
adapting the patient to the device. Subsequently, the IMT was allowed to be done at home three
times a week on days when it did not attend the SCR.
To determine the handgrip load, we used the WCT Fitness® HandGrip dynamometer and
followed the dynamometer protocol of the American Society of Hand Therapists (2). Therefore,
the patient was positioned in sedestation in a chair with a straight back and without support for
the arms, with arms adducted and neutrally rotated shoulders, elbow flexed at 90º and forearm
in neutral position. After being in the oriented position, the patient was asked to squeeze the
dynamometer as tightly as possible, making three attempts on each hand with a one-minute rest
between attempts. At the end, we considered 10% of the maximum strength obtained from the
non-dominant hand.
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Table 1. Exercise protocol for February (adaptive training) and March to June (conditioning training).
Employed
Month/Year
Volume
Duration
Interval
Intensity
Exercise
3 series of 10
1 minute
Inspiratory
Light
inspirations
recovery
Muscle Training
Borg from 7 to 9*
2 times weekly
between sets
4 monoarticular
1 minute
Light
Neuromuscular
exercises¥
recovery
Omni from 1 to 3#
Exercise
2 sets of 10 reps
February/2019
between sets
Borg from 7 to 9*
2 times weekly
Light
1 minute
Borg from 7 to 9*,
2 sets
Treadmill
30 seconds
recovery
reaching an
2 times weekly
between sets
average speed of
0.8 km/h
5 series at 10%
of the load
1 minute of
1 minute
Moderate
Handgrip
obtained in
continuous
recovery
Omni from 3 to 5#
dynamometry
handgrip
between sets
Borg from 11 to 13*
2 times weekly
4 monoarticular
2 minutes of
Moderate
Neuromuscular
exercises¥
recovery
Omni from 3 to 5#
March to
Exercise
2 sets of 12 reps
between sets
Borg from 11 to 13*
June/2019
2 times weekly
Moderate
Borg from 11 to 13*
2 minutes of
Heating speed on
5 sets
Treadmill
1 minute
recovery
average 1.1km/h
2 times weekly
between sets
Conditioning
speed on average at
2.0km/h
¥Elbow flexion, elbow extension, knee flexion and knee extension, *Borg used for the patient to achieve the proposed
muscle effort, without exceeding a cardiorespiratory effort > 9 in the adaptation training and >13 in the conditioning
training, #Subjective Effort Scale referred to active muscles.

RESULTS
Table 2 represents the comparison of the Doppler echocardiogram variables and the percentage
of improvement before and after the patient joined an SCR program. It is worth mentioning that
both exams were performed by the same echocardiographer and the patient’s weight and height,
respectively, were 72 kg and 167 cm in both exams.
From the results obtained in Table 2, we can highlight a 15% decrease in left ventricular mass, a
27% decrease in final stroke volume, a 22% decrease in final diastolic volume, and a 4%
reduction in the diameter of the Left Atrium (LA), which reflects a decrease in dilation and
cardiac functional improvement.
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Table 2. Echocardiographic measurements comparing pre and post SCR values.
Pre SCR
Post SCR
Reference
Evolution
Variables
12/02/2019
07/05/2019
values*
percentage
Left Atrium diameter (mm)
46
44
40
4%
Final Diastolic Volume (ml)
130
102
46 - 106
22%
Final stroke volume (ml)
44
32
14 - 42
27%
Diastolic thickness of LVPW (mm)
9
9
7 - 10
Diastolic Thickness of the Septum (mm)
14
14
7 - 10
Left Ventricular Mass (g)
236
201
67 - 162
15%
Mass of the LV/ Body Surface (g/m2)
131
111
43 - 95
15%
Ejection Fraction (%) #
66
69
54 - 74
5%
*Reference values of the American Society of Echocardiography and the European Cardiovascular Imaging
Association (6), #Ejection Fraction (Simpson), LVPW: Left Ventricular Posterior Wall, LV: Left Ventricle.

Figure 1 represents the MLHFQ score (an important tool to assess QL in individuals with HF),
which was applied before and after the SCR. After the SCR, there was an improvement in the
physical and emotional aspects, such as: easier walking, carrying out domestic activities, and
decreased concern.

Figure 1. Score obtained in the QL test before and after the SCR.

The SCR program also made it possible to reduce the dosage of the drug, propranolol
hydrochloride, in half. In the last month of SCR, a patient started to show bradycardia and
hypotension during and after exercise. In the face of these events, the same was referred to the
cardiologist who reduced the dosage from 40 mg 2x a day to 20 mg 2x a day
DISCUSSION
The results of this case report suggest that a SCR program is a cost-effective adjunctive treatment
in HCM, capable of promoting RMR and improving functionality and QL. It is well established
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in the literature that physical exercise is capable of inducing RMR, both for dilation and
concentric hypertrophy (5). Although we have not seen regression of concentric hypertrophy,
we have seen reversal of dilation. This is observed in Table 2, in which there is a substantial
reduction in the final diastolic and systolic volumes, in the left atrium diameter, and in the
indexed and non-indexed left ventricular mass. These improvements, both numerically and
percentage-wise, are reinforced by the ECO-dependent evaluation character. The fact that he
was the same evaluator before and after the program, and the fact that he has followed the
patient for ten consecutive years, reinforces the reliability of echocardiographic results.
Furthermore, it should also be noted that not only did the left ventricular systolic and diastolic
volumes regress, but also that they adjusted now to the are within normal limits values of these
variables.
The increased volume of the LA is an important predictor of negative cardiovascular outcomes
(3, 6). The regression of LA dilation (as seen in Table 2), even an improvement of 4%, for a patient
with HCM is extremely significant. The decrease in LA is reflected in a reduction in the risk of
mortality and hospitalization, incidence of atrial fibrillation and stroke, as well as in an increase
in life expectancy (4).
The mechanisms by which exercise triggers RMR have been described in the literature for some
time. We highlight here the effect of aerobic intensity cyclic exercise on microRNAs, used in the
patient's program. Experimental studies with rats demonstrate that physical exercise induces
the action of microRNAs 21, 132, 155, 146b, 208b, 212 and 214, which are indicated to induce
RMR and improve cardiac function (14). Although, in this case, cardiac function has undergone
a slight quantitative improvement (ejection fraction increasing by 5%), it was significant in the
patient's clinical context. The significant improvement in QL assessed by the Minnesota
questionnaire, points this out. The evolution of performing ADL as performing domestic
activities were the points most highlighted by the patient after the SCR program. We cannot
forget that other factors, such as the decrease in sympathetic hyperactivity (common in these
patients), improvement in the activity of the renin-angiotensin system, and adaptations in the
peripheral muscles, may have had as strong an impact on QL as the central improvements (4,
12).
In HCM cases, some patients may have syncope. At the beginning of treatment, this was one of
the main complaints of the patient, along with dyspnea on light and moderate exertion, possibly
caused by a myocardial hypoperfusion and increased oxygen demand characteristic of HCM
(1). After the five months of SCR, the patient reported that she was no longer presenting with
episodes of syncope, a condition that contributed to the improvement of her emotional
perception and, consequently, in QL.
Another point to be highlighted in this case is the work of the multidisciplinary team. The
benefits mentioned above were due to a personalized physical exercise prescription,
individualized according to the patient's clinical and biological characteristics. For that, the
moments of reevaluation and periodization of training carried out by the multidisciplinary
team, composed of doctors (assistant cardiologist and arrhythmologist) and physiotherapists
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(specialists in Cardiovascular Rehabilitation) made all the difference in the relevance of the
results obtained.
Finally, we point out that, as this is a case report, the results presented here must be analyzed
with caution and impartiality. Despite this, this case report advances something new, the
possibility of exercise causing reversal of dilation in HCM, and is something that in our
knowledge has not yet been reported in the literature. We know that a case report is only based
on the hierarchical scale of scientific evidence. However, it is able to shed light on fields that are
still little explored in science, the main contribution of this work. In view of the above, this study
suggests that an individualized and personalized SCR program is an adjuvant treatment capable
of promoting RMR and improving the QL and functionality of patients with HCM.
REFERENCES
1. Cao Y, Zhang PY. Review of recent advances in the management of hypertrophic cardiomyopathy. Eur Rev Med
Pharmacol Sci 21(22): 5207-5210, 2017.
.
2. Fess EE. Grip strength. In: Clinical assessment recommendations. 2nd Ed. Chicago: American Society of Hand
Therapists; 1992.
3. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the
diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology
Foundation/American Heart Association task force on practice guidelines developed in collaboration with the
American Ass. J Am Coll Cardiol 58(25): 212–260, 2011.
4. Klempfner R, Kamerman T, Schwammenthal E, Nahshon A, Hay I, Goldenberg I, et al. Efficacy of exercise
training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training
program in a cardiac rehabilitation center. Eur J Prev Cardiol 22(1): 13-19, 2015.
5. Konhilas JP, Watson PA, Maass A, Boucek DM, Horn T, Stauffer BL, et al. Exercise can prevent and reverse the
severity of hypertrophic cardiomyopathy. Circ Res 98(4): 540-548, 2006.
6. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for quantification
of cardiac chambers by echocardiography in adults: An update from the American society of echocardiography
and the European cardiovascular imaging association citation for original document: Recommendations for cardiac.
J Am Soc Echocardiogr 28: 1–39, 2015.
7. Martinelli Filho M, Zimerman LI, Lorga AM, Vasconcelos JTM RAJ. Guidelines for implantable electronic cardiac
devices of the Brazilian society of cardiology. Arq Bras Cardiol 89(6): 210–238, 2007.
8. Mattos BP, Torres MAR, Freitas VC, Scolari FL, Loreto MS. Ventricular arrhythmias and left ventricular
hypertrophy in hypertrophic cardiomyopathy. Arq Bras Cardiol 5(100): 452-459, 2013
9. Navalta JW, Stone WJ, Lyons TS. Ethical issues relating to scientific discovery in exercise science. Int J Exerc Sci
12(1): 1-8, 2019.
10. Oliveira FTO, Petto J, Esquivel MS, Dias CMCC, Oliveira ACS, Aras R. Comparison of the strength and
resistance of inspirational muscles between assets and sedentary. J Phys Res 8(2): 223-229, 2018.
11. Reineck E, Rolston B, Bragg-Gresham JL, Salberg L, Baty L, Kumar S, et al. Physical activity and other health
behaviors in adults with hypertrophic cardiomyopathy. Am J Cardiol 111(7): 1034–1039, 2013.

International Journal of Exercise Science

1025

http://www.intjexersci.com

Int J Exerc Sci 14(2): 1018-1026, 2021
12. Saberi S, Wheeler M, Bragg-Gresham J, Hornsby W, Agarwal PP, Attili A, et al. Effect of moderate-intensity
exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: A randomized
clinical trial. JAMA 317(13): 1349-1357, 2017.
13. Saberi S, Day SM. Exercise and hypertrophic cardiomyopathy: Time for a change of heart. Circulation 137(5):
419-421, 2018.
14. Souza RWA, Fernandez GJ, Cunha JPQ, Piedade WP, Soares LC, Souza PAT, et al. Regulation of cardiac
microRNAs induced by aerobic exercise training during heart failure. Am J Physiol Heart Circ Physiol 309(10):
1629–1641, 2015.

International Journal of Exercise Science

1026

http://www.intjexersci.com

